Kimberly is Founder and CEO of KKH Advisors, a life sciences strategic communications firm. With two decades of media and communications expertise, she has advised Fortune 500 companies to early-stage startups on business transformation, corporate and executive positioning, crisis and issues management, and financial communications, with a focus on IPO readiness and execution.Prior to founding KKH Advisors, Kimberly was a Senior Director on the life sciences capital markets team at FTI Consulting (NYSE:FCN), one of the largest financial consulting firms worldwide. Prior to FTI, she was the Global Editor at BioPharm Insight, part of the Financial Times Group. Combining her extensive experience in financial communications consulting with her journalistic acumen, Kimberly brings a unique blend of strategic vision and counsel to her work, enabling her to drive impactful communication strategies for clients across the biotech sector.An award-winning journalist, she is a National Press Foundation Fellow, a regular speaker at industry conferences and has shared her expertise at universities and startup accelerators nationwide. Kimberly is a Board Member at the Galien Foundation, and a Limited Partner at Array Ventures. She received a B.A in Psychology from New York University.